Alerts

Shares of Airgain (NSDQ: AIRG) have exploded to the upside after a much better than expected earnings report released last week.  I am recommending taking profits on the position with a near 50% gain in the shares as of the open of trading on November 15.  Shares were initially… Read More

Certain biotech stocks, such as Gilead are likely to respond to changes in the healthcare system brought about by Trumpcare.  This trade has yet to develop fully, yet has an excellent chance to deliver a significant profit once the stock breaks up or down.  Read More

The rising uncertainty about a healthcare system under President Trump is starting to sink in and the market seems to be in sell mode for pharmaceutical companies. So it’s a good time to sell Opko Health (NSDQ: OPK), a company specializing in hormone treatments and kidney dialysis related treatments, with… Read More

It’s time to close out the Anthem straddle. The trade has delivered an excellent gain and we don’t want to let the time premium and the upcoming weekend erode into our profit.SELL to close Anthem December 16, 120 Strike Price Put (ATNM121616P120)  Bought on 8/29/16 at $5.15. Closing price on 11/10/16… Read More

The post-election rally seems to have some short-term legs and the healthcare stocks are putting on quite a show. The early indications suggest that money is aggressively flowing into the health insurance companies. As a result, a change of tactics is called for.I recommend the sale of the Johnson &… Read More

I am increasingly concerned about the markets as the election nears. As a result, I am recommending a straddle option strategy which will protect our portfolio if there is a major move, either up or down in this market. I will have more on Monday’s BTP weekly. Read More

McKesson (NYSE: MCK) one the largest medical supply wholesalers in the world delivered extremely disappointing earnings after the close on 10/27/16 and the stock delivered a rapid and significant decline falling as low as $140 after closing at $160.50.  Earnings per share came in at $1.34 per share vs. estimates of… Read More

Medidata Solutions (NSDQ: MDSO), a leading provider of cloud-based research trial and recordkeeping software for pharmaceutical and biotech companies, sold off this morning after it delivered better than expected revenues and earnings. The stock initially rallied but eventually succumbed to aggressive selling. This is not an encouraging activity pattern so… Read More

The current market is offering an excellent opportunity to buy protection against election uncertainty and the general trend toward decreasing payments for pharmaceutical companies from Medicare and private insurers. Buy & Johnson December 16, 2016 115 Put Option (JNJ_121616P115) up to $4.   Read More